Investing in medical technology innovation: Time to change direction
Life Sciences & Health Care
October 11 | 1 p.m. ET | 17:00 GMT
Host: Terry Hisey, principal, Deloitte Consulting LLP
1 Overview CPE credit | Specialized Knowledge
A recent decline in early-stage medical technology (medtech) investment is threatening future innovation. How can various industry stakeholders reverse this trajectory to continue bringing novel technologies to patients? We'll discuss:
- Medtech innovation at the crossroads—factors leading to the current investment crisis.
- Strategies for advancing early-stage medtech investment, including structured financing, strategic partnerships, changes to governance and operating models, alternate funding for startups, and US tax reform.
- De-risking reimbursement and commercialization, including new approaches for developing effective value propositions, generating evidence, and increasing the likelihood of reimbursement.
Participants will learn results of recent research findings from Deloitte and AdvaMed and explore new approaches to investing in medtech innovation.